Kinney Horn

This profile gathers the share dealings of Kinney Horn across 2 companies, led by Olema Pharmaceuticals, Inc. and Immunome Inc. We count 35 filings; the first trade dates from 18 May 2021 and the latest from 4 August 2026.

The open-market record consists of 18 sales worth €4.5M, with no purchase. Other entries cover 1 share grant and 15 option exercises. In 2026 alone, the filings show no purchases and 2 sales.

On 6 August 2026 came the latest disclosure, an open-market sale for €2.0M in Immunome Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.